<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR18">
 <label>18.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Church</surname>
    <given-names>LD</given-names>
   </name>
   <name>
    <surname>McDermott</surname>
    <given-names>MF</given-names>
   </name>
  </person-group>
  <article-title>Canakinumab, a fully-human mAb against IL-1beta for the potential treatment of inflammatory disorders</article-title>
  <source>Curr Opin Mol Ther</source>
  <year>2009</year>
  <volume>11</volume>
  <fpage>81</fpage>
  <lpage>89</lpage>
  <?supplied-pmid 19169963?>
  <pub-id pub-id-type="pmid">19169963</pub-id>
 </element-citation>
</ref>
